USPTO serial 85354181
ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 28, 2012
- Examiner
- FAHRENKOPF, PAUL
- Law office
- TMEG LAW OFFICE 101
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Endo Pharmaceuticals Solutions Inc.
Malvern, PA
Other trademarks owned by Endo Pharmaceuticals Solutions Inc.
Endo Pharmaceuticals Solutions Inc.
Chadds Ford, PA
Other trademarks owned by Endo Pharmaceuticals Solutions Inc.
Endo Pharmaceuticals Solutions Inc.
Chadds Ford, PA
Other trademarks owned by Endo Pharmaceuticals Solutions Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
Camille M. Miller Cozen O'Connor1650 Market StreetSuite 2800Philadelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed materials, namely, brochures and pamphlets on the subject of premature puberty and hormonal treatment for the condition | SECTION 8 - CANCELLED | — |
| 044 | Medical services, namely, providing on-line information on the subject of premature puberty and hormonal treatment for the condition | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Endo Pharmaceuticals Solutions Inc.
- Other trademarks owned by Endo Pharmaceuticals Solutions Inc.
- Other trademarks owned by Endo Pharmaceuticals Solutions Inc.
- Other trademarks in Class 016
- Other trademarks in Class 044
- Similar marks named ONCE-YEARLY SUPPRELIN LA (HISTRELIN ACETATE) SUBCUTANEOUS IMPLANT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 28, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 9, 2022 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Dec 22, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 28, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jun 3, 2017 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 3, 2017 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jun 3, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 18, 2017 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 28, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 25, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 25, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 26, 2014 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 28, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 13, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2011 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 9, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 9, 2011 | ALIE | ASSIGNED TO LIE | — |
| Oct 18, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 18, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 18, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 18, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 6, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2011 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Jun 29, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2011 | NWAP | NEW APPLICATION ENTERED | — |